These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8157277

  • 1. Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody.
    Wong JP, Stadnyk LL, Saravolac EG.
    Immunology; 1994 Feb; 81(2):280-4. PubMed ID: 8157277
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
    Kostolanský F, Mucha V, Slováková R, Varecková E.
    Acta Virol; 2002 Feb; 46(4):229-36. PubMed ID: 12693859
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice.
    Epstein SL, Lo CY, Misplon JA, Lawson CM, Hendrickson BA, Max EE, Subbarao K.
    J Immunol; 1997 Feb 01; 158(3):1222-30. PubMed ID: 9013963
    [Abstract] [Full Text] [Related]

  • 7. Effects of tremella-alginate-liposome encapsulation on oral delivery of inactivated H5N3 vaccine.
    Cheng HC, Chang CY, Hsieh FI, Yeh JJ, Chien MY, Pan RN, Deng MC, Liu DZ.
    J Microencapsul; 2011 Feb 01; 28(1):55-61. PubMed ID: 20945970
    [Abstract] [Full Text] [Related]

  • 8. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.
    J Virol; 2005 Oct 01; 79(19):12401-7. PubMed ID: 16160167
    [Abstract] [Full Text] [Related]

  • 9. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
    Lu J, Guo Z, Pan X, Wang G, Zhang D, Li Y, Tan B, Ouyang L, Yu X.
    Respir Res; 2006 Mar 23; 7(1):43. PubMed ID: 16553963
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 23; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 11. Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
    Quan FS, Compans RW, Cho YK, Kang SM.
    Vaccine; 2007 Jan 04; 25(2):272-82. PubMed ID: 16945454
    [Abstract] [Full Text] [Related]

  • 12. Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection.
    Garulli B, Meola M, Stillitano MG, Kawaoka Y, Castrucci MR.
    Virology; 2007 May 10; 361(2):274-82. PubMed ID: 17222437
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T, Watanabe I, Ito S, Fujii H, Moriyama M, Tamura S, Takahashi H, Sawa H, Chiba J, Kurata T, Sata T, Hasegawa H.
    J Virol; 2005 Mar 10; 79(5):2910-9. PubMed ID: 15709010
    [Abstract] [Full Text] [Related]

  • 15. Prevention and treatment of lethal influenza A virus bronchopneumonia in mice by monoclonal antibody against haemagglutinin stem region.
    Lipatov AS, Gitelman AK, Smirnov YuA.
    Acta Virol; 1997 Dec 10; 41(6):337-40. PubMed ID: 9607093
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M, Velumani S, He F, Karuppannan AK, Geng GY, Yin LK, Kwang J.
    Virology; 2008 Oct 25; 380(2):412-20. PubMed ID: 18786689
    [Abstract] [Full Text] [Related]

  • 20. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL, Misplon JA, Lawson CM, Subbarao EK, Connors M, Murphy BR.
    J Immunol; 1993 Jun 15; 150(12):5484-93. PubMed ID: 8390536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.